These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 9208140)
1. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy. Majima M; Kawashima N; Hiroshi I; Katori M Br J Pharmacol; 1997 Jun; 121(4):723-30. PubMed ID: 9208140 [TBL] [Abstract][Full Text] [Related]
2. Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction. Griesbacher T; Legat FJ Br J Pharmacol; 1997 Mar; 120(5):933-9. PubMed ID: 9138701 [TBL] [Abstract][Full Text] [Related]
4. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release. Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy. Vianna RM; Calixto JB Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617 [TBL] [Abstract][Full Text] [Related]
6. The nonpeptide B2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception. Griesbacher T; Amann R; Sametz W; Diethart S; Juan H Br J Pharmacol; 1998 Jul; 124(6):1328-34. PubMed ID: 9720808 [TBL] [Abstract][Full Text] [Related]
7. Characterization of FR173657, a novel nonpeptide B2 antagonist: in vitro and in vivo studies. Inamura N; Asano M; Kayakiri H; Hatori C; Oku T; Nakahara K Can J Physiol Pharmacol; 1997 Jun; 75(6):622-8. PubMed ID: 9276139 [TBL] [Abstract][Full Text] [Related]
8. Effects of a nonpeptide bradykinin B2 receptor antagonist, FR167344, on different in vivo animal models of inflammation. Asano M; Hatori C; Inamura N; Sawai H; Hirosumi J; Fujiwara T; Nakahara K Br J Pharmacol; 1997 Dec; 122(7):1436-40. PubMed ID: 9421292 [TBL] [Abstract][Full Text] [Related]
9. Suppressive effect of distinct bradykinin B2 receptor antagonist on allergen-evoked exudation and leukocyte infiltration in sensitized rats. Bandeira-Melo C; Calheiros AS; Silva PM; Cordeiro RS; Teixeira MM; Martins MA Br J Pharmacol; 1999 May; 127(2):315-20. PubMed ID: 10385228 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandin receptors EP2, EP3, and IP mediate exudate formation in carrageenin-induced mouse pleurisy. Yuhki K; Ueno A; Naraba H; Kojima F; Ushikubi F; Narumiya S; Oh-ishi S J Pharmacol Exp Ther; 2004 Dec; 311(3):1218-24. PubMed ID: 15316088 [TBL] [Abstract][Full Text] [Related]
11. MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs. Valenti C; Cialdai C; Giuliani S; Lecci A; Tramontana M; Meini S; Quartara L; Maggi CA J Pharmacol Exp Ther; 2005 Nov; 315(2):616-23. PubMed ID: 16027229 [TBL] [Abstract][Full Text] [Related]
12. Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats. Hirata M; Hayashi I; Yoshimura K; Ishii K; Soma K; Ohwada T; Kakita A; Majima M Br J Pharmacol; 2002 Jan; 135(1):29-36. PubMed ID: 11786477 [TBL] [Abstract][Full Text] [Related]
13. The role of kinin B1 in the plasma extravasation of carrageenin-induced pleurisy. Hayashi I; Amano H; Ishihara K; Kumagai Y; Yoshimura H; Majima MC Life Sci; 2002 Jan; 70(8):937-49. PubMed ID: 11853231 [TBL] [Abstract][Full Text] [Related]
14. Antiinflammatory effects of Tacrolimus in a mouse model of pleurisy. Pereira R; Medeiros YS; Fröde TS Transpl Immunol; 2006 Aug; 16(2):105-11. PubMed ID: 16860713 [TBL] [Abstract][Full Text] [Related]
15. Effect of invertebrate serine proteinase inhibitors on carrageenan-induced pleural exudation and bradykinin release. Malavazi-Piza KC; Araújo MS; Godinho RO; Tanaka AS Int Immunopharmacol; 2004 Oct; 4(10-11):1401-8. PubMed ID: 15313437 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses. Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994 [TBL] [Abstract][Full Text] [Related]
17. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation. Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H J Med Chem; 1998 Nov; 41(23):4587-98. PubMed ID: 9804698 [TBL] [Abstract][Full Text] [Related]
18. Effects of the non-peptide B2 receptor antagonist FR173657 in models of visceral and cutaneous inflammation. Griesbacher T; Legat FJ Inflamm Res; 2000 Oct; 49(10):535-40. PubMed ID: 11089906 [TBL] [Abstract][Full Text] [Related]
19. Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammation. Félétou M; Lonchampt M; Robineau P; Jamonneau I; Thurieau C; Fauchère JL; Villa P; Ghezzi P; Prost JF; Canet E J Pharmacol Exp Ther; 1995 Jun; 273(3):1078-84. PubMed ID: 7791078 [TBL] [Abstract][Full Text] [Related]
20. Activation of plasma kallikrein-kinin system and its significant role in pleural fluid accumulation of rat carrageenin-induced pleurisy. Uchida Y; Tanaka K; Harada Y; Ueno A; Katori M Inflammation; 1983 Jun; 7(2):121-31. PubMed ID: 6345379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]